Terminal inversion duplications of the short arm of chromosome 8 are one of the more common chromosome rearrangements in humans. We report an infant with multiple congenital anomalies, in whom karyotype analysis showed a terminal inversion duplication of 8p including additional material at the distal end of the derivative chromosome, shown to be of chromosome 18q origin. Terminal inversion duplications of 8p are the result of meiotic recombination between inverted olfactory gene receptor repeats in 8p. This recombination generates a dicentric intermediate that breaks during anaphase, and the broken chromosome end is stabilized by telomere healing or telomere capture. The origin of the telomeric region in the majority of constitutional chromosome deletions studied to date was shown to be from telomere healing; the de novo addition of telomeric repeats. In the proband a cytogenetically detectable piece of chromosome 18q was present on the distal end of the derivative 8, suggesting that this chromosome was stabilized by telomere capture of 18q. FISH analyses of additional cases may yield information as to whether telomere capture or telomere-healing events are the predominant mechanism of chromosome stabilization in terminal inversion duplications of 8p.   

1.
Ballif BC, Kashork CD, Shaffer LG: FISHing for mechanisms of cytogenetically defined terminal deletions using chromosome-specific subtelomeric probes. Eur J hum Genet 8:764–770 (2000).
2.
de Die-Smulders CE, Engelen JJ, Schrander-Stumpel CT, Govaerts LC, de Vries B, Vles JS, Wagemans A, Schijns-Fleuren S, Gillessen-Kaesbach G, Fryns JP: Inversion duplication of the short arm of chromosome 8: clinical data on seven patients and review of the literature. Am J med Genet 59:369–374 (1995).
3.
Fan YS, Siu VM: Molecular cytogenetic characterization of a derivative chromosome 8 with an inverted duplication of 8p21.3→p23.3 and a rearranged duplication of 8q24.13→qter. Am J med Genet 102:266–271 (2001).
4.
Flint J, Craddock CF, Villegas A, Bentley DP, Williams HJ, Galanello R, Cao A, Wood WG, Ayyub H, Higgs DR: Healing of broken human chromosomes by the addition of telomeric repeats. Am J hum Genet 55:505–512 (1994).
5.
Flint J, Rochette J, Craddock CF, Dode C, Vignes B, Horsley SW, Kearney L, Buckle VJ, Ayyub H, Higgs DR: Chromosomal stabilisation by a subtelomeric rearrangement involving two closely related Alu elements. Hum molec Genet 5:1163–1169 (1996).
6.
Floridia G, Piantanida M, Minelli A, Dellavecchia C, Bonaglia C, Rossi E, Gimelli G, Croci G, Franchi F, Gilgenkrantz S, Grammatico P, Dalpra L, Wood S, Danesino C, Zuffardi O: The same molecular mechanism at the maternal meiosis I produces mono- and dicentric 8p duplications. Am J hum Genet 58:785–796 (1996).
7.
Giglio S, Broman KW, Matsumoto N, Calvari V, Gimelli G, Neumann T, Ohashi H, Voullaire L, Larizza D, Giorda R, Weber JL, Ledbetter DH, Zuffardi O: Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements. Am J hum Genet 68:874–883 (2001).
8.
Guo WJ, Callif-Daley F, Zapata MC, Miller ME: Clinical and cytogenetic findings in seven cases of inverted duplication of 8p with evidence of a telomeric deletion using fluorescence in situ hybridization. Am J med Genet 58:230–236 (1995).
9.
Melek M, Shippen DE: Chromosome healing: spontaneous and programmed de novo telomere formation by telomerase. Bioessays 18:301–308 (1996).
10.
Meltzer PS, Guan XY, Trent JM: Telomere capture stabilizes chromosome breakage. Nature Genet 4:252–255 (1993).
11.
Minelli A, Floridia G, Rossi E, Clementi M, Tenconi R, Camurri L, Bernardi F, Hoeller H, Previde Re C, Maraschio P, et al: D8S7 is consistently deleted in inverted duplications of the short arm of chromosome 8 (inv dup 8p). Hum Genet 92:391–396 (1993).
12.
Mitchell JJ, Vekemans M, Luscombe S, Hayden M, Weber B, Richter A, Sparkes R, Kojis T, Watters G, Der Kaloustian VM: U-type exchange in a paracentric inversion as a possible mechanism of origin of an inverted tandem duplication of chromosome 8. Am J med Genet 49:384–387 (1994).
13.
Preston RJ: Telomeres, telomerase and chromosome stability. Radiat Res 147:529–634 (1997).
14.
Schinzel A: Unbalanced Chromosome Aberrations in Man (Walter de Gruyter, Berlin 2001).
15.
Silverman GA, Schneider SS, Massa HF, Flint A, Lalande M, Leonard JC, Overhauser J, van den Engh G, Trask BJ: The 18q– syndrome: analysis of chromosomes by bivariate flow karyotyping and the PCR reveals a successive set of deletion breakpoints within 18q21.2→q22.2. Am J hum Genet 56:926–937 (1995).
16.
Varley H, Di S, Scherer SW, Royle NJ: Characterization of terminal deletions at 7q32 and 22q13.3 healed by De novo telomere addition. Am J hum Genet 67:610–622 (2000).
17.
Verma RS, Babu A: Human Cytogenetics. Principles and Techniques. (McGraw-Hill, New York 1994).
18.
Vermeesch JR, Falzetti D, Van Buggenhout G, Fryns JP, Marynen P: Chromosome healing of constitutional chromosome deletions studied by microdissection. Cytogenet Cell Genet 81:68–72 (1998).
19.
Wilkie AO, Lamb J, Harris PC, Finney RD, Higgs DR: A truncated human chromosome 16 associated with alpha thalassaemia is stabilized by addition of telomeric repeat (TTAGGG)n. Nature 346:868–871 (1990).
20.
Wong AC, Ning Y, Flint J, Clark K, Dumanski JP, Ledbetter DH, McDermid HE: Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. Am J hum Genet 60:113–120 (1997).
© 2002 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.